Pt Hetzer Medical Stock Earnings Per Share
MEDS Stock | 50.00 0.00 0.00% |
PT Hetzer Medical fundamentals help investors to digest information that contributes to PT Hetzer's financial success or failures. It also enables traders to predict the movement of MEDS Stock. The fundamental analysis module provides a way to measure PT Hetzer's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PT Hetzer stock.
MEDS |
PT Hetzer Medical Company Earnings Per Share Analysis
PT Hetzer's Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
Competition |
According to the company disclosure, PT Hetzer Medical has an Earnings Per Share of 0.0 times. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Medical Instruments & Supplies industry. The earnings per share for all Indonesia stocks is 100.0% higher than that of the company.
Did you try this?
Run Idea Breakdown Now
Idea BreakdownAnalyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
All Next | Launch Module |
MEDS Fundamentals
Profit Margin | (0.08) % | |||
Operating Margin | 0.12 % | |||
Shares Outstanding | 1.56 B | |||
Shares Owned By Insiders | 8.00 % | |||
Price To Sales | 5.97 X | |||
Revenue | 43.99 B | |||
Gross Profit | 53.98 B | |||
EBITDA | 7.68 B | |||
Book Value Per Share | 45.78 X | |||
Number Of Employees | 25 | |||
Market Capitalization | 231.25 B |
About PT Hetzer Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PT Hetzer Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PT Hetzer using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PT Hetzer Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in MEDS Stock
PT Hetzer financial ratios help investors to determine whether MEDS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in MEDS with respect to the benefits of owning PT Hetzer security.